Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

The ocular surface

Showing results (151-160 of 1,486) with videos related to

Pageof 149
Sort By:
The Ocular Surface|November 30, 2006
Should you be a clinical investigator for a new pharmaceutical?Gary D Novack
The Ocular Surface|October 12, 2013
Fluorescein: its use in investigation of lacrimal characteristicsJuan Murube
The Ocular Surface|October 12, 2013
Four characteristics and a model of an effective tear film lipid layer (TFLL)P Ewen King-Smith, Melissa D Bailey, Richard J Braun
The Ocular Surface|October 12, 2013
Current medical treatment of ocular mucous membrane pemphigoidBianka Sobolewska, Christoph Deuter, Manfred Zierhut
The Ocular Surface|October 12, 2013
Statistical approaches to assessing single and multiple outcome measures in dry eye therapy and diagnosisAlan Tomlinson, Mario Hair, Angus McFadyen
The Ocular Surface|February 14, 2009
Pterygium: its treatment with beta therapyJuan Murube
The Ocular Surface|November 1, 2006
Challenges and pitfalls in clinical trials of treatments for dry eyeGary N Foulks
The Ocular Surface|November 1, 2006
Anti-inflammatory therapy of dry eyeStephen C Pflugfelder
The Ocular Surface|November 1, 2006
Personal profileAdrienne Graves
The Ocular Surface|November 1, 2006
How are tear lubricant products regulated in the US?Gary D Novack
Pageof 149

Showing results (151-160 of 1,486) with videos related to

Sort By:
Pageof 149
The Ocular Surface|November 30, 2006
Should you be a clinical investigator for a new pharmaceutical?Gary D Novack
The Ocular Surface|October 12, 2013
Fluorescein: its use in investigation of lacrimal characteristicsJuan Murube
The Ocular Surface|October 12, 2013
Four characteristics and a model of an effective tear film lipid layer (TFLL)P Ewen King-Smith, Melissa D Bailey, Richard J Braun
The Ocular Surface|October 12, 2013
Current medical treatment of ocular mucous membrane pemphigoidBianka Sobolewska, Christoph Deuter, Manfred Zierhut
The Ocular Surface|October 12, 2013
Statistical approaches to assessing single and multiple outcome measures in dry eye therapy and diagnosisAlan Tomlinson, Mario Hair, Angus McFadyen
The Ocular Surface|February 14, 2009
Pterygium: its treatment with beta therapyJuan Murube
The Ocular Surface|November 1, 2006
Challenges and pitfalls in clinical trials of treatments for dry eyeGary N Foulks
The Ocular Surface|November 1, 2006
Anti-inflammatory therapy of dry eyeStephen C Pflugfelder
The Ocular Surface|November 1, 2006
Personal profileAdrienne Graves
The Ocular Surface|November 1, 2006
How are tear lubricant products regulated in the US?Gary D Novack
Pageof 149